GlobeNewswire Medical EquipmentCodex · 实盘不做把握 8/10不做原因:无增量信息
北京时间·🕒 发布 19:30:00·⟳ 抓取 19:31:56·⚡ 决策 09-01 22:39:09 +3h07m·55.9 天前
FocalTherics将参加H.C. Wainwright全球投资会议并进行投资者会谈
该公告只是常规会议日程和管理层会谈安排，不改变收入、利润、监管、产品、订单或资本结构预期，缺乏可交易催化。
📄 原文GlobeNewswire Medical Equipment↗ 原文
FocalTherics™ to Present at the H.C. Wainwright 28th Annual Global Investment Conference
FocalTherics ™ to Present at the H.C. Wain w right 28 th Annual Global Investment Conference Company to Present and Hos…
不做 FocalTherics（FOCL.US）
常规投资者会议出席公告，无订单、审批、财务指引或产品商业化新增事实，缺乏可交易 edge。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
事件事实是FocalTherics参加投行会议并提供 webcast 链接；这类日程公告本身不产生新增销售、审批、融资或业绩指引，也没有明确业务量级可估。即使标的可交易，当前信息不足以形成正期望方向交易，因此回避。
🔎 新鲜度:最早出现 2026-09-01 · 扩散 low · price-in 风险 low ↗
主要风险
- 若会议期间另行披露临床、订单、融资或指引更新，需要按新事件重新研判。
先例如何影响了这次决策
对本次决策的影响:先例不足不影响结论；本事件本身缺少订单、业绩、审批或产品商业化增量。
方向:常规投行会议出席通知不提供稳定方向读数。
涨幅量级:无可用于校准幅度的高相似基本面事件。
形态:未进入外部先例测算，因为源文本已足以判定没有新增基本面催化。
原文全文
展开原文 · 1,583 字
FocalTherics
™
to Present at
the
H.C. Wain
w
right
28
th
Annual Global Investment Conference
Company to Present and Host 1x1 Investor Meetings on
T
uesday
and Wednesday, September 15
th
-16
th
, 2026
AUSTIN, Texas, Sept. 01, 2026 (GLOBE NEWSWIRE) -- FocalTherics™ (Nasdaq: FOCL) (the “Company”), a global leader in robotic focal therapy, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to present at the upcoming H.C. Wainwright 28th Annual Global Investment Conference being held September 14-16, 2026 in New York, New York. Rhodes, together with Ken Mobeck, Chief Financial Officer, will also host 1x1 investor meetings at the conference on Tuesday and Wednesday, September 15-16, 2026.
Date
: Tuesday, September 15, 2026
Time
: 10:30-11:00 AM ET
Format
: Presentation
Webcast
:
https://journey.ct.events/view/678a5096-f9a4-4a67-b503-ad650aca3c59
The live and archived webcast of the presentation can be accessed in the Investors section of the Company’s website
here
.
About
FocalTherics
A recognized global leader in robotic focal therapy, FocalTherics develops, manufactures, and markets minimally invasive medical devices worldwide to treat various conditions using proprietary focused ultrasound technology. The Company’s flagship platform, Focal One® Robotic HIFU, combines advanced imaging, real-time treatment planning, robotic precision, and HIFU technology to deliver personalized focal therapy designed to optimize clinical outcomes while preserving quality of life.
Investor Contact
Louisa Smith
Gilmartin Group
Investor.relations@focalone.com
™
to Present at
the
H.C. Wain
w
right
28
th
Annual Global Investment Conference
Company to Present and Host 1x1 Investor Meetings on
T
uesday
and Wednesday, September 15
th
-16
th
, 2026
AUSTIN, Texas, Sept. 01, 2026 (GLOBE NEWSWIRE) -- FocalTherics™ (Nasdaq: FOCL) (the “Company”), a global leader in robotic focal therapy, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to present at the upcoming H.C. Wainwright 28th Annual Global Investment Conference being held September 14-16, 2026 in New York, New York. Rhodes, together with Ken Mobeck, Chief Financial Officer, will also host 1x1 investor meetings at the conference on Tuesday and Wednesday, September 15-16, 2026.
Date
: Tuesday, September 15, 2026
Time
: 10:30-11:00 AM ET
Format
: Presentation
Webcast
:
https://journey.ct.events/view/678a5096-f9a4-4a67-b503-ad650aca3c59
The live and archived webcast of the presentation can be accessed in the Investors section of the Company’s website
here
.
About
FocalTherics
A recognized global leader in robotic focal therapy, FocalTherics develops, manufactures, and markets minimally invasive medical devices worldwide to treat various conditions using proprietary focused ultrasound technology. The Company’s flagship platform, Focal One® Robotic HIFU, combines advanced imaging, real-time treatment planning, robotic precision, and HIFU technology to deliver personalized focal therapy designed to optimize clinical outcomes while preserving quality of life.
Investor Contact
Louisa Smith
Gilmartin Group
Investor.relations@focalone.com
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。